Bids Are Invited For The Purpose Of This Term Of Reference (Tr) Is The Acquisition Of Industrialized Medicines, Incorporated Into The List Of Essential Medicines And Hospital Solutions Of The Rio De Janeiro State Health Foundation - Fserj (29795390), Intended For The Initial Supply Of The Baixada State Institute Of Oncology (Onco-Baixada), A State Health Unit In The Implementation Phase, Under The Management Of Fserj, According To Management Contract No. 002/2021 Signed Between This Institution And The State Of Rio De Janeiro, Through The State Department Of Health.

Pharmacological Group: Antineoplastics, Active Ingredient: Abiraterone Acetate, Pharmaceutical Form: Tablet, Concentration / Dosage: 250, Unit: Mg, Volume: N/A, Presentation: N/A, Accessory: N/A, Active Ingredient: Bicalutamide, Pharmaceutical Form: Coated Tablet, Concentration / Dosage: 50, Volume: No Applicable, Presentation: Packet, Accessory: Not Applicable, Active Ingredient: Cetuximab, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 5, Unit: Mg/Ml, Volume: 20 Ml, Presentation: Ampoule Vial, Active Ingredient: Flutamide, Presentation: Not Applicable, Active Ingredient: Mesylate Imatinib, Concentration/Dosage: 400, 08/05/2026 - 10:14:29, Active Ingredient: Irinotecan Hydrochloride, Concentration/Dosage: 20, Volume: 5Ml, Active Ingredient: Oxaliplatin, Pharmaceutical Form: Injectable Lyophilic Powder, Concentration/Dosage: 100